相关实验视频

Updated: Jan 14, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

在多发性骨髓瘤患者用静脉注射免疫球蛋白进行感染预防,这些患者接受了Teclistamab治疗

Michael Sheu¹, Sofia Molina Garcia², Meera Patel¹

¹Cleveland Clinic, Internal Medicine, Cleveland, Ohio, USA.

|October 23, 2025

概括

静脉注射免疫球蛋白 (IVIG) 预防在多发性骨髓瘤患者中减少了因感染而导致的住院治疗,这些患者接受了双特异性抗体 - - teclistamab 的治疗. 这一发现支持IVIG作为高风险群体感染的有效策略.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

针对B细胞成熟抗原的双特异性抗体,如特克利斯塔马布,增加了多发性骨髓瘤 (MM) 患者的感染风险.
损坏的幽默免疫力和低血糖球蛋白血症有助于这种增加的易感性.

研究的目的:

评估静脉注射免疫球蛋白 (IVIG) 预防在缓解感染相关住院治疗 (IRHs) 的有效性.
评估IVIG对在接受德克利斯塔马布治疗的MM患者减少传染性并发症的影响.

主要方法:

从2022年12月到2024年3月在陶西格癌症中心进行的回顾性研究.
对用德克利斯塔马布治疗的MM患者的分析,比较IVIG预防期间和之后的IRH发病率.
主要终点:每名患者每天的IRH发病率.

主要成果:

在44名患者中,17名患者经历了19次需要住院治疗的传染性发作.
在IVIG期间感染发病率较低 (5次发作/4,378天),而非IVIG期间 (14次发作/4,619天).
非IVIG和IVIG组之间的感染发病率比为2.65 (p=0.027),表明IVIG显著减少.

结论:

接受德克利斯塔马布治疗的MM患者由于免疫力受损而容易感染.
通过IVIG预防,该患者队伍的感染发病率显著降低.
IVIG是一种可行的预防措施,可降低接受双特异抗体治疗的MM患者的感染风险.

关键词:

双特异性抗体双特异性抗体免疫球蛋白是一种免疫球蛋白.感染感染感染多发性骨髓瘤是一种多发性骨髓瘤.

更多相关视频

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...